Oleg Tsuprykov Selected Research

Osteopontin

1/2012

Early urinary and plasma biomarkers for experimental diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oleg Tsuprykov Research Topics

Disease

7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2012
5	Albuminuria 05/2016 - 01/2012
4	Chronic Renal Insufficiency 01/2020 - 05/2016
3	Fibrosis (Cirrhosis) 01/2019 - 11/2013
2	Rickets (Rachitis) 01/2018 - 01/2012
1	Fatty Liver 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2018
1	Glucose Intolerance 01/2018
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018
1	Reperfusion Injury 07/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Overnutrition 11/2016
1	digital ulcers 11/2014
1	Hepatorenal Syndrome 11/2014
1	Pulmonary Hypertension 11/2014
1	Cystic Kidney Diseases (Cystic Kidney Disease) 11/2014
1	Type 2 Diabetes Mellitus (MODY) 11/2014
1	Cardiomegaly (Heart Hypertrophy) 11/2013
1	Renovascular Hypertension (Goldblatt Syndrome) 11/2013
1	Pathologic Constriction (Stenosis) 11/2013
1	Hypertension (High Blood Pressure) 11/2013
1	Body Weight (Weight, Body) 01/2012
1	Vascular Calcification 01/2012
1	Neoplasms (Cancer) 01/2012
1	Vitamin D Deficiency 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2012
1	Diabetes Mellitus 01/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2012
1	Bone Diseases (Bone Disease) 01/2012
1	Osteoporosis 01/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2011

Drug/Important Bio-Agent (IBA)

5	LinagliptinIBA 01/2019 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2014
4	Telmisartan (Micardis)FDA Link 05/2016 - 01/2012
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 11/2014
3	Angiotensin Receptor AntagonistsIBA 01/2020 - 01/2012
3	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2019 - 11/2014
3	Vitamin D FDA LinkGeneric 01/2018 - 01/2012
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022 - 01/2012
2	Contrast MediaIBA 01/2017 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 11/2013 - 01/2012
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2012 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 01/2011
1	CreatinineIBA 01/2019
1	Collagenases (Collagenase)FDA Link 01/2019
1	GelatinasesIBA 01/2019
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2019
1	Cystatin CIBA 01/2019
1	CalciumIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 07/2017
1	MicronutrientsIBA 11/2016
1	Endothelin Receptor AntagonistsIBA 11/2014
1	salicylhydroxamic acid (SHAM)IBA 11/2013
1	Blood Glucose (Blood Sugar)IBA 01/2012
1	Metalloproteases (Metalloproteinases)IBA 01/2012
1	Fatty Acid-Binding ProteinsIBA 01/2012
1	ClusterinIBA 01/2012
1	Fatty Acid Binding Protein 3IBA 01/2012
1	Soluble Guanylyl CyclaseIBA 01/2012
1	OsteopontinIBA 01/2012
1	Lipocalin-2IBA 01/2012
1	riociguatIBA 01/2012
1	nephrinIBA 01/2012
1	MineralsIBA 01/2012

Therapy/Procedure

1	Therapeutics 05/2016
1	Surgical Instruments (Clip) 11/2013